DK597188A - 9,10-dihydroxy-perhydroisoquinolinderivater til anvendelse som mellemprodukt ved fremstilling af 14-hydroxymorphinanderivater - Google Patents

9,10-dihydroxy-perhydroisoquinolinderivater til anvendelse som mellemprodukt ved fremstilling af 14-hydroxymorphinanderivater

Info

Publication number
DK597188A
DK597188A DK597188A DK597188A DK597188A DK 597188 A DK597188 A DK 597188A DK 597188 A DK597188 A DK 597188A DK 597188 A DK597188 A DK 597188A DK 597188 A DK597188 A DK 597188A
Authority
DK
Denmark
Prior art keywords
derivatives
hydroxymorphinander
perhydroisoquinoline
dihydroxy
preparation
Prior art date
Application number
DK597188A
Other languages
English (en)
Other versions
DK160987C (da
DK160987B (da
DK597188D0 (da
Inventor
Ivo Monkovic
Carol Bachand
Henry Wong
Gary Lim
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/669,795 external-priority patent/US4058531A/en
Priority claimed from US05/769,808 external-priority patent/US4139534A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK597188A publication Critical patent/DK597188A/da
Publication of DK597188D0 publication Critical patent/DK597188D0/da
Publication of DK160987B publication Critical patent/DK160987B/da
Application granted granted Critical
Publication of DK160987C publication Critical patent/DK160987C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK597188A 1976-03-23 1988-10-27 9,10-dihydroxy-perhydroisoquinolinderivater til anvendelse som mellemprodukt ved fremstilling af 14-hydroxy-morphinanderivater DK160987C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US05/669,795 US4058531A (en) 1976-03-23 1976-03-23 Process for the preparation of 14-hydroxymorphinan derivatives
US66979576 1976-03-23
US76980877 1977-02-17
US05/769,808 US4139534A (en) 1977-02-17 1977-02-17 Process for the preparation of 14-hydroxymorphinan derivatives

Publications (4)

Publication Number Publication Date
DK597188A true DK597188A (da) 1988-10-27
DK597188D0 DK597188D0 (da) 1988-10-27
DK160987B DK160987B (da) 1991-05-13
DK160987C DK160987C (da) 1991-11-11

Family

ID=27100195

Family Applications (2)

Application Number Title Priority Date Filing Date
DK123877A DK155322C (da) 1976-03-23 1977-03-21 Fremgangsmaade til fremstilling af 14-hydroxymorphinan-derivater og farmaceutisk acceptable syreadditionssalte deraf samt mellemprodukt til anvendelse ved fremgangsmaaden
DK597188A DK160987C (da) 1976-03-23 1988-10-27 9,10-dihydroxy-perhydroisoquinolinderivater til anvendelse som mellemprodukt ved fremstilling af 14-hydroxy-morphinanderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK123877A DK155322C (da) 1976-03-23 1977-03-21 Fremgangsmaade til fremstilling af 14-hydroxymorphinan-derivater og farmaceutisk acceptable syreadditionssalte deraf samt mellemprodukt til anvendelse ved fremgangsmaaden

Country Status (8)

Country Link
JP (1) JPS52136176A (da)
CA (1) CA1086723A (da)
CH (1) CH629783A5 (da)
DK (2) DK155322C (da)
FI (1) FI61486C (da)
LU (1) LU77000A1 (da)
NL (2) NL189846C (da)
SE (1) SE431749B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0373510U (da) * 1989-11-15 1991-07-24

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634429A (en) * 1969-09-30 1972-01-11 Hoffmann La Roche Morphinan derivatives and preparation thereof
CA919668A (en) * 1970-06-20 1973-01-23 Murakami Masuo Morphinan derivatives
BE788478A (fr) * 1971-09-08 1973-03-06 Bristol Myers Co Procede de preparation de composes analgesiques
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
SE7703236L (sv) 1977-09-24
DK160987C (da) 1991-11-11
NL7703000A (nl) 1977-09-27
JPS6139938B2 (da) 1986-09-06
JPS52136176A (en) 1977-11-14
LU77000A1 (da) 1977-10-03
CA1086723A (en) 1980-09-30
DK155322B (da) 1989-03-28
NL189846B (nl) 1993-03-16
CH629783A5 (en) 1982-05-14
NL960022I1 (nl) 1996-12-02
NL189846C (nl) 1993-08-16
DK155322C (da) 1989-09-11
FI61486B (fi) 1982-04-30
FI770865A (da) 1977-09-24
DK160987B (da) 1991-05-13
DK123877A (da) 1977-09-24
DK597188D0 (da) 1988-10-27
FI61486C (fi) 1982-08-10
SE431749B (sv) 1984-02-27

Similar Documents

Publication Publication Date Title
DK467377A (da) Fremgangsmaade til fremstilling af 1,4,3,6-dianhydro-d-glucitol-2-nitrat.
DK118277A (da) Fremgangsmade til fremstilling af n-5-tetrazololyl)-4-oxo-4h-pyrimido (2,1-b)benzothiazol-3-carboxamider
DK157293C (da) Propionitril til anvendelse som mellemprodukt ved fremstilling af 6-aminosubstituerede-5-r3-2,4-diaminopyrimidin-3-oxider
DK117779A (da) Fremgangsmaade til fremstilling af 2,6-dialkoxybenzamider
DK243477A (da) Fremgangsmade til fremstilling af 10,19-dihydrovitamin d forbindelser
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK187577A (da) Fremgangsmade til fremstilling af 1,4-benzodioxsnderivater
DK227277A (da) Fremgangsmade til fremstilling af 1,3-disubstituerede nitrosourinstoffer
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
DK63990A (da) 7-aminocephalosporinderivater til anvendelse som mellemprodukt til fremstilling af sephalosporinderivater
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK233377A (da) Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner
DK307378A (da) Fremgangsmaade til fremstilling af 1,2,4-oxadiazoler
DK126077A (da) Fremgangsmade til fremstilling af 2,6-di-tert-butylphenol
DK301177A (da) Fremgangsmade til fremstilling af 6a,10a-cishexahydrodibenzopyranoner
DK160987C (da) 9,10-dihydroxy-perhydroisoquinolinderivater til anvendelse som mellemprodukt ved fremstilling af 14-hydroxy-morphinanderivater
DK345477A (da) Fremgangsmaade til fremstilling af 2,3-dichloranisol
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan
DK544476A (da) Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether
DK139681B (da) 3,4-Dehydro-eburnameninderivater til anvendelse som mellemprodukt ved fremstilling af eburnameninderivater.
DK412077A (da) Fremgangsmaade til fremstilling af 1,1-dichlor-1,3-butadien
DK554176A (da) Fremgangsmade til fremstilling af 3,4-dideoxykanamycin b
DK77878A (da) Fremgangsmaade til fremstilling af 1,2,4-benzotriazin-di-n-oxid-derivater
DK144698C (da) 2,4-diamino-6-halogen-5-benzylpyrimidiner til anvendelse som mellemprodukter ved fremstilling af 2,4-diamino-5-benzylpyrimidiner